Terms: = Prostate cancer AND BLM, MGC131620, 641, ENSG00000197299, MGC131618, RECQ2, RECQL2, RECQL3, MGC126616, BS
336 results:
1. Cumulative cancer locations on prostate biopsy and active surveillance outcomes in the MRI era.
Fletcher SA; Mamawala MM; Holler AE; Bhanji Y; Macura KJ; de la Calle CM; Pavlovich CP
Prostate; 2024 Jun; 84(8):723-730. PubMed ID: 38476030
[TBL] [Abstract] [Full Text] [Related]
2. The Impact of Inherited Genetic Variation on DNA Methylation in prostate cancer and Benign Tissues of African American and European American Men.
Delgado D; Gillard M; Tong L; Demanelis K; Oliva M; Gleason KJ; Chernoff M; Chen L; Paner GP; Vander Griend D; Pierce BL
Cancer Epidemiol Biomarkers Prev; 2024 Apr; 33(4):557-566. PubMed ID: 38294689
[TBL] [Abstract] [Full Text] [Related]
3. Pembrolizumab for metastatic castration-resistant prostate cancer: trials and tribulations.
Tsai AK; Kagalwalla S; Langer J; Le-Kumar T; Le-Kumar V; Antonarakis ES
Expert Opin Biol Ther; 2024; 24(1-2):51-62. PubMed ID: 38284349
[TBL] [Abstract] [Full Text] [Related]
4. Risk of Clinically Significant prostate cancer after a Nonsuspicious prostate MRI-A Comparison with the General Population.
Pylväläinen J; Hoffström J; Kenttämies A; Auvinen A; Mirtti T; Rannikko A
Cancer Epidemiol Biomarkers Prev; 2024 May; 33(5):749-756. PubMed ID: 38270536
[TBL] [Abstract] [Full Text] [Related]
5. Elevated serum CA199 levels in patients suffering type 2 diabetes vs. various types of cancer.
Zhuang Y; Cai Q; Hu X; Huang H
BMC Endocr Disord; 2024 Jan; 24(1):9. PubMed ID: 38212751
[TBL] [Abstract] [Full Text] [Related]
6. Trends and age, sex, and race disparities in time to second primary cancer from 1990 to 2019.
Leung TH; El Helali A; Wang X; Ho JC; Pang H
Cancer Med; 2023 Dec; 12(24):22316-22324. PubMed ID: 38063337
[TBL] [Abstract] [Full Text] [Related]
7. Vegetarian diets and risk of all-cause mortality in a population-based prospective study in the United States.
Blackie K; Bobe G; Takata Y
J Health Popul Nutr; 2023 Nov; 42(1):130. PubMed ID: 37996932
[TBL] [Abstract] [Full Text] [Related]
8. Development of machine learning prognostic models for overall survival of prostate cancer patients with lymph node-positive.
Peng ZH; Tian JH; Chen BH; Zhou HB; Bi H; He MX; Li MR; Zheng XY; Wang YW; Chong T; Li ZL
Sci Rep; 2023 Oct; 13(1):18424. PubMed ID: 37891423
[TBL] [Abstract] [Full Text] [Related]
9. Does a patient-specific bladder-filling protocol affect bladder volume and dose in postprostatectomy radiotherapy?
Yalman D; Köylü M; Duran Ö
Int Urol Nephrol; 2024 Mar; 56(3):999-1006. PubMed ID: 37821762
[TBL] [Abstract] [Full Text] [Related]
10. Role of 18F-NaF PET/CT in bone metastases.
Zhang-Yin J; Panagiotidis E
Q J Nucl Med Mol Imaging; 2023 Dec; 67(4):249-258. PubMed ID: 37750848
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic value of pretreatment inflammatory markers in localised prostate cancer before radical prostatectomy.
Grogg JB; Rizzi G; Gadient J; Wettstein MS; Affentranger A; Fankhauser CD; Eberli D; Poyet C
World J Urol; 2023 Oct; 41(10):2693-2698. PubMed ID: 37749262
[TBL] [Abstract] [Full Text] [Related]
12. The trajectory of sarcopenia following diagnosis of prostate cancer: A systematic review and meta-analysis.
Kovač MB; Pavlin T; Čavka L; Ribnikar D; Spazzapan S; Templeton AJ; Šeruga B
J Geriatr Oncol; 2023 Sep; 14(7):101594. PubMed ID: 37482497
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic biomarkers in the use of radium-223 in patients with metastatic castration-resistent prostate cancer.
Vidal M; Cárdenas-Perilla R; Delgado A; Morón S; Londoño Blair JL; Vega I; Correa Ochoa JJ; Rojas J
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(5):310-318. PubMed ID: 37419250
[TBL] [Abstract] [Full Text] [Related]
14. PARP1 negatively regulates transcription of blm through its interaction with HSP90AB1 in prostate cancer.
Huang M; Chen L; Guo Y; Ruan Y; Xu H
J Transl Med; 2023 Jul; 21(1):445. PubMed ID: 37415147
[TBL] [Abstract] [Full Text] [Related]
15. Relationship Between Pretreatment Body Composition and Clinical Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving First-Line Ipilimumab Plus Nivolumab.
McManus HD; Zhang D; Schwartz FR; Wu Y; Infield J; Ho E; Armstrong AJ; George DJ; Kruse D; Gupta RT; Harrison MR
Clin Genitourin Cancer; 2023 Dec; 21(6):e429-e437.e2. PubMed ID: 37271698
[TBL] [Abstract] [Full Text] [Related]
16. Implications of metastatic stage at presentation in docetaxel naïve metastatic castrate resistant prostate cancer.
Roy S; Wallis CJD; Morgan SC; Kishan AU; Le ATT; Malone J; Sun Y; Spratt DE; Saad F; Malone S
Prostate; 2023 Jul; 83(10):912-921. PubMed ID: 37071764
[TBL] [Abstract] [Full Text] [Related]
17. Frequency of superscan on bone scintigraphy: A systematic review.
Kovacsne A; Kozon I; Bentestuen M; Zacho HD
Clin Physiol Funct Imaging; 2023 Sep; 43(5):297-304. PubMed ID: 37070619
[TBL] [Abstract] [Full Text] [Related]
18. Head-to-head Comparison of the Diagnostic Accuracy of prostate-specific Membrane Antigen Positron Emission Tomography and Conventional Imaging Modalities for Initial Staging of Intermediate- to High-risk prostate cancer: A Systematic Review and Meta-analysis.
Chow KM; So WZ; Lee HJ; Lee A; Yap DWT; Takwoingi Y; Tay KJ; Tuan J; Thang SP; Lam W; Yuen J; Lawrentschuk N; Hofman MS; Murphy DG; Chen K
Eur Urol; 2023 Jul; 84(1):36-48. PubMed ID: 37032189
[TBL] [Abstract] [Full Text] [Related]
19. Impact of prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography on the Therapeutic Decision of prostate Carcinoma Primary Staging: A Retrospective Analysis at the Brazilian National Public Health System.
da Silva ACB; de Toledo LGM; de Carvalho Fernandes R; Ziroldo AR; Sawczyn GV; Alarcon ST; Lewin F
Ann Surg Oncol; 2023 Jul; 30(7):4541-4549. PubMed ID: 36995451
[TBL] [Abstract] [Full Text] [Related]
20. Deep learning based identification of bone scintigraphies containing metastatic bone disease foci.
Ibrahim A; Vaidyanathan A; Primakov S; Belmans F; Bottari F; Refaee T; Lovinfosse P; Jadoul A; Derwael C; Hertel F; Woodruff HC; Zacho HD; Walsh S; Vos W; Occhipinti M; Hanin FX; Lambin P; Mottaghy FM; Hustinx R
Cancer Imaging; 2023 Jan; 23(1):12. PubMed ID: 36698217
[TBL] [Abstract] [Full Text] [Related]
[Next]
